According to Verrica Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$4.10. In 2022 the company made an earnings per share (EPS) of -HK$6.36 an increase over its 2021 EPS that were of -HK$10.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$4.14 | -34.91% |
2022 | -HK$6.36 | -36.59% |
2021 | -HK$10.02 | -24.56% |
2020 | -HK$13.29 | 51.33% |
2019 | -HK$8.78 | -26.34% |
2018 | -HK$11.92 | 213.54% |
2017 | -HK$3.80 |